Literature DB >> 16045829

Epidemiology of systemic vasculitis.

Suzanne E Lane1, Richard Watts, David G I Scott.   

Abstract

The systemic vasculitides are heterogeneous conditions of unknown etiology characterized by inflammation and necrosis of different sized blood vessels. Wegener's Granulomatosis, microscopic polyangiitis, and Churg Strauss syndrome are associated with anti-neutrophil cytoplasmic antibodies and affect small and medium blood vessels. They are very rare in childhood and peak in the 65 to 70 year old age group. Wegener's Granulomatosis appears to be more common in the North of Europe compared with the South. All are more common in whites compared with other populations. Genetic and environmental factors, including infection, drugs, and silica, are important in etiology. Giant cell arteritis is predominantly a disease of whites over the age of 50. It appears more common in individuals with Nordic descent. Incidence may be increasing over time and cyclical variation in disease may reflect an infectious etiology. Takayasu arteritis is a disease of the aorta and its branches, however pulmonary and cardiac arteries may be involved. Patients are usually under 40-years of age at presentation and there are no apparent differences in incidence or clinical characteristics/aortic involvement across the globe. Kawasaki disease (KD) and Henoch-Schonlein purpura are diseases of children and rarely affect adults. Both have been reported to be more common in Asians than whites. The incidence of KD is higher in Japan and China compared with other regions. No definite trigger factors have been found, but KD has been linked to infection, house dust mite and chemicals, and Henoch-Schonlein purpura to a pesticide and drugs.

Entities:  

Mesh:

Year:  2005        PMID: 16045829     DOI: 10.1007/s11926-005-0036-5

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  48 in total

Review 1.  Kawasaki disease: is it caused by an infectious agent?

Authors:  A J Lloyd; C Walker; M Wilkinso
Journal:  Br J Biomed Sci       Date:  2001       Impact factor: 3.829

2.  Epidemiology of vasculitis in Europe.

Authors:  R A Watts; S E Lane; D G Scott; W Koldingsnes; H Nossent; M A Gonzalez-Gay; C Garcia-Porrua; G A Bentham
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

3.  Primary systemic vasculitis: clinical features and mortality.

Authors:  S E Lane; R A Watts; L Shepstone; D G I Scott
Journal:  QJM       Date:  2005-01-17

4.  Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies.

Authors:  M Tidman; R Olander; C Svalander; D Danielsson
Journal:  J Intern Med       Date:  1998-08       Impact factor: 8.989

5.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Authors:  E C Hagen; M R Daha; J Hermans; K Andrassy; E Csernok; G Gaskin; P Lesavre; J Lüdemann; N Rasmussen; R A Sinico; A Wiik; F J van der Woude
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

6.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2005-02-15

7.  The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population.

Authors:  C Nordborg; H Johansson; V Petursdottir; E Nordborg
Journal:  Rheumatology (Oxford)       Date:  2003-04       Impact factor: 7.580

8.  High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement.

Authors:  Kerstin W A Westman; Daina Selga; Per-Erik Isberg; Anna Bladström; Håkan Olsson
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

9.  Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.

Authors:  P K Li; J C Leung; F M Lai; A Wang; S F Lui; C B Leung; K N Lai
Journal:  Am J Nephrol       Date:  1994       Impact factor: 3.754

10.  Allergic disorders in systemic vasculitis: a case-controlled study.

Authors:  M J Cuadrado; D D'Cruz; M Lloyd; F Mujic; M A Khamashta; G R Hughes
Journal:  Br J Rheumatol       Date:  1994-08
View more
  27 in total

Review 1.  Complications of long-term therapy for ANCA-associated systemic vasculitis.

Authors:  Nadezhda Wall; Lorraine Harper
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

Review 2.  Pediatric vasculitis.

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

3.  PAN's labyrinth: a multidisciplinary delayed diagnosis and patient's perspective.

Authors:  Emma Louise Barlow; Owen Seddon; Brendan Healy
Journal:  BMJ Case Rep       Date:  2016-01-05

4.  Large aorta and narrow arteries: two short stories of too long diagnostic delay.

Authors:  Doron Boltin; Jonathan Wollman; Marina Anouk; Yoav Goor; Jacob Ablin; Hanan Guzner Gur; Dan Caspi; Ori Elkayam
Journal:  Rheumatol Int       Date:  2007-03-17       Impact factor: 2.631

Review 5.  Aortitis.

Authors:  Heather L Gornik; Mark A Creager
Journal:  Circulation       Date:  2008-06-10       Impact factor: 29.690

6.  Granulomatosis with polyangiitis (Wegener's granulomatosis): a rare variant of sudden natural death.

Authors:  Birthe Heitkötter; Cornelius Kuhnen; Sven Schmidt; Daniel Wittschieber
Journal:  Int J Legal Med       Date:  2017-10-31       Impact factor: 2.686

7.  Giant cell arteritis as a cardiovascular entity.

Authors:  P Houthuizen; P E Polak; M A L Edelbroek; C H Peels
Journal:  Neth Heart J       Date:  2009-08       Impact factor: 2.380

Review 8.  Eosinophilic granulomatosis with polyangiitis without respiratory symptoms or asthma in an adolescent: case report and literature review.

Authors:  Gülçin Otar Yener; Zahide Ekici Tekin; Neşe Çallı Demirkan; Selçuk Yüksel
Journal:  Rheumatol Int       Date:  2017-11-30       Impact factor: 2.631

Review 9.  French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides).

Authors:  Benjamin Terrier; Raphaël Darbon; Cécile-Audrey Durel; Eric Hachulla; Alexandre Karras; Hélène Maillard; Thomas Papo; Xavier Puechal; Grégory Pugnet; Thomas Quemeneur; Maxime Samson; Camille Taille; Loïc Guillevin
Journal:  Orphanet J Rare Dis       Date:  2020-12-29       Impact factor: 4.123

Review 10.  Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis.

Authors:  Aman Sharma; Kusum Sharma
Journal:  J Clin Exp Hepatol       Date:  2013-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.